13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-16, with 105 holding rows worth $2,348,705,000.
- Accession
- 0001140361-16-065661
- Filer
- CIK 1009258
- Filed
- 2016-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 105 entries on the cover page, a total value of $2,348,705,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,348,708,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON PHARMA PLC | G4617B105 | SHS | 13,740,261 | $227,676,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 1,832,535 | $84,938,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 5,506,028 | $82,535,000 | thousands by filing date | |
| HWAY 1.5 7/18 | 422245AB6 | Bond 30/360P2 U | 76,925,000 | $70,595,000 | thousands by filing date | principal |
| HORIZON PHARMA INVT LTD | 44052TAB7 | NOTE 2.500% 3/1 | 82,600,000 | $70,475,000 | thousands by filing date | principal |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 1,675,385 | $67,937,000 | thousands by filing date | |
| AETNA INC NEW | 00817Y108 | COM | 591,465 | $66,451,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 3,089,785 | $63,032,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 2,236,701 | $60,928,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 822,000 | $60,318,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 1,709,400 | $59,043,000 | thousands by filing date | |
| ADEPTUS HEALTH | 006855100 | Common Stock | 956,533 | $53,126,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 11,572,125 | $52,190,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 5,996,691 | $50,132,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 674,373 | $48,656,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 3,467,512 | $46,534,000 | thousands by filing date | |
| AMERISOURCEBERGEN COR | 000307108 | COMMON | 2,294,936 | $45,417,000 | thousands by filing date | |
| FLAMEL TECHNOLOGIES-SP ADR | 338488109 | SPON | 4,072,809 | $44,964,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 511,457 | $43,085,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAB2 | NOTE 3.25011/0 | 40,000,000 | $38,632,000 | thousands by filing date | principal |
| UNIVERSAL AMERN CORP NEW | 91338E101 | COM | 5,285,500 | $37,738,000 | thousands by filing date | |
| HEARTWARE INTERNATIONAL | 422368AA8 | NOTE | 39,226,000 | $36,498,000 | thousands by filing date | principal |
| WRIGHT MED GROUP INC | 98235TAE7 | NOTE 2.000% 2/1 | 40,050,000 | $35,961,000 | thousands by filing date | principal |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 45,000,000 | $35,876,000 | thousands by filing date | principal |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,113,654 | $35,704,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 2,632,482 | $32,011,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 3,264,588 | $30,654,000 | thousands by filing date | |
| ZELTIQ AESTHETICS INC | 98933Q108 | COM | 1,104,417 | $29,996,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAA4 | NOTE 2.250%12/1 | 40,941,000 | $29,871,000 | thousands by filing date | principal |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 9,529,361 | $28,112,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 680,000 | $27,628,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 175,000 | $27,519,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 870,634 | $27,355,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 1,029,410 | $27,228,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 817,806 | $26,620,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 1,873,471 | $25,386,000 | thousands by filing date | |
| HEALTHWAYS INC | 422245100 | COM | 2,475,387 | $24,977,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760CAA5 | MTNF 2.625% 6/0 | 29,831,000 | $23,643,000 | thousands by filing date | principal |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 4,398,862 | $23,182,000 | thousands by filing date | |
| KEMPHARM INC COM NEW | 488445107 | Stock | 1,420,497 | $20,597,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 3,055,603 | $20,411,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 3,001,302 | $20,229,000 | thousands by filing date | |
| RITEAID CORP | 767754104 | COM | 2,393,072 | $19,504,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 1,193,811 | $18,934,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 3,381,439 | $18,125,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 1,150,700 | $16,110,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 3,732,412 | $15,564,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385PAA6 | NOTE 2.750% 2/0 | 27,715,000 | $15,353,000 | thousands by filing date | principal |
| Elevance Health, Inc. | 036752103 | COM | 102,000 | $14,177,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 327,626 | $13,701,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 2,456,261 | $12,674,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 1,169,042 | $12,626,000 | thousands by filing date | |
| IMPRIVATA INC | 45323J103 | Cmn | 983,366 | $12,420,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 943,433 | $12,170,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 5,878,015 | $10,287,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,265,343 | $9,794,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 517,920 | $9,711,000 | thousands by filing date | |
| INVUITY INC | 46187J205 | COM NEW | 1,327,009 | $9,581,000 | thousands by filing date | |
| ENDOCHOICE HLDGS INC COM | 29272U103 | COM | 1,823,309 | $9,499,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 353,491 | $9,329,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 606,222 | $9,227,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 2,587,215 | $8,408,000 | thousands by filing date | |
| CEPHEID | 15670RAC1 | DBCV 1.250% 2/0 | 7,750,000 | $6,917,000 | thousands by filing date | principal |
| LOXO ONCOLOGY INC | 548862101 | COM | 251,000 | $6,862,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 559,097 | $6,603,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 948,934 | $6,187,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 787,257 | $6,093,000 | thousands by filing date | |
| ARALEZ PHARMACEUTICALS INC | 03852X100 | COM | 1,644,583 | $5,838,000 | thousands by filing date | |
| JAZZ INVESTMENTS I LTD | 472145AB7 | NOTE 1.875% 8/1 | 5,000,000 | $5,111,000 | thousands by filing date | principal |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 2,397,855 | $4,988,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 458,332 | $4,945,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 569,895 | $4,764,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 49,797 | $4,721,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 464,541 | $4,604,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 3,200,000 | $4,544,000 | thousands by filing date | |
| EGALET CORP | 28226B104 | COM | 597,123 | $4,096,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 1,069,914 | $4,055,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 374,800 | $4,014,000 | thousands by filing date | |
| PSIVIDA CORP | 74440J101 | COM | 1,492,824 | $4,001,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 848,000 | $3,417,000 | thousands by filing date | |
| STEADYMED LTD | M84920103 | SHS | 1,346,744 | $3,313,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 643,580 | $3,244,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HOLDING | 890260201 | COM NEW | 1,315,551 | $3,170,000 | thousands by filing date | |
| ACURA PHARMACEUTICALS INC COM | 00509L802 | COM | 1,025,641 | $2,903,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H100 | COM | 397,085 | $2,776,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 275,000 | $2,137,000 | thousands by filing date | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 235,294 | $2,054,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 471,259 | $1,975,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 172,307 | $1,594,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 250,000 | $1,553,000 | thousands by filing date | |
| TRUPANION INC | 898202106 | COM | 155,236 | $1,529,000 | thousands by filing date | |
| ALPHATEC HOLDINGS INC | 02081G102 | COM | 4,982,738 | $1,196,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 229,000 | $1,136,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 3,500 | $938,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 662,971 | $935,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 165,097 | $892,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 68,779 | $873,000 | thousands by filing date | |
| AMRN 3.5 1/32 | 220480AB3 | Bond 30/360P2 U | 1,000,000 | $821,000 | thousands by filing date | principal |
| Pfizer Inc. | 717081103 | COM | 25,000 | $741,000 | thousands by filing date | |
| Alliqua BioMedical Inc | 019621200 | COM NEW | 667,246 | $547,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 985,693 | $532,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617118 | ORD SHS | 30,000 | $498,000 | thousands by filing date | |
| RENNOVA HEALTH INC COM | 759757107 | Stock | 353,933 | $265,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 75,293 | $221,000 | thousands by filing date | |
| RENNOVA HEALTH INC | 759757115 | *W EXP 12/30/202 | 645,161 | $51,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-16-065661 | this filing | 2016-05-16 | acceptance time not in the bulk data set |